Products
Online Inquiry
Our Products Cannot Be Used As Medicines Directly For Personal Use.
Welcome! For price inquiries, please feel free to contact us through the form on the left side. We will get back to you as soon as possible.
AAL-993
Cat No.
CEI-0953
Description
A potent and selective inhibitor of VEGFR-1 (IC50=130nM), VEGFR-2 (IC50=23nM) and VEGFR-3 (IC50=18nM). At higher concentrations it inhibits PDGFR (640nM), c-Kit (236nM) and CSF-1R (380nM). Inactive at other kinases such as EGFR, FGFR-1, CDK-1, Tie-2, c-Met, IGF-1R, c-Src and c-Abl. X-ray crystal studies on AAL-993 complexed to the catalytic domain of diphosphorylated VEGFR- 2 indicates that it binds to an inactive conformation of the protein. Cell permeable and active in vivo. Inhibits VEGF-induced angiogenesis (mouse model) (1).
Abbr
AAL-993(VEGFA)
Alias
2-((4-Pyridyl)methyl)amino-N-(3 (trifluoromethyl)phenyl)benzamide
Appearance
Light yellow powder
Product Overview
VEGF inhibitor
CAS No.
269390-77-4
Molecular Weight
371.1
Purity
>98% (TLC); NMR (Conforms)
Synonyms
2-((4-Pyridyl)methyl)amino-N-(3 (trifluoromethyl)phenyl)benzamide
Targets
VEGF
Molecular Formula
C20H16F3N3O
Solubility
May be dissolved in DMSO (>25 mg/ml); or Ethanol (15 mg/ml)
Download
Download Datasheet